Shopping Cart
Remove All
Your shopping cart is currently empty
Selicrelumab (RG-7876) is an antibody targeting CD40 with potential anti-tumor activity that induces changes in the tumor microenvironment in patients with resectable pancreatic cancer and may be used to study pancreatic cancer.
| Pack Size | Price | USA Warehouse | Global Warehouse | Quantity |
|---|---|---|---|---|
| 1 mg | $193 | - | In Stock | |
| 5 mg | $473 | - | In Stock | |
| 10 mg | $679 | - | In Stock | |
| 25 mg | $987 | - | In Stock | |
| 50 mg | $1,380 | - | In Stock |
| Description | Selicrelumab (RG-7876) is an antibody targeting CD40 with potential anti-tumor activity that induces changes in the tumor microenvironment in patients with resectable pancreatic cancer and may be used to study pancreatic cancer. |
| Synonyms | RO-7009789, RO7009789, RG-7876, RG7876 |
| Reactivity | Human |
| Application | Functional assay |
| Antibody Type | Monoclonal |
| Endotoxin | <1.0 EU/mg |
| Conjucates | Unconjugated |
| Gene ID | |
| Uniprot ID | |
| Target | TNFRSF5/CD40 |
| Molecular Weight | 146.2 kDa |
| Cas No. | 1622140-49-1 |
| Isotype | Human IgG2 kappa |
| Recommended Isotype Control |
| Storage | store at low temperature | -20°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2026 TargetMol Chemicals Inc. All Rights Reserved.